Local gene therapy with anti-CD40 siRNA plus rapamycin prolongs survival and decreases post-transplant renal acute rejection

I. Herrero-Fresneda; O. Gulias; M. Franquesa; R. Pluvinet; A. Vidal; V. Nacher; J. M. Cruzado; I. Rama; J. Aran; J. M. Grinyo; J. Torras

Local gene therapy with anti-CD40 siRNA plus rapamycin prolongs survival and decreases post-transplant renal acute rejection

I. Herrero-Fresneda
, O. Gulias
, M. Franquesa
, R. Pluvinet
, A. Vidal
, V. Nacher
, J. M. Cruzado
, I. Rama
, J. Aran
, J. M. Grinyo
, J. Torras

Research output: Indexed journal article › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	68-68
Number of pages	1
Journal	Transplant International
Volume	20
Publication status	Published - Sept 2007
Externally published	Yes

Cite this

@article{8f1c081a87ee46c3bf2ef1431d0e000d,

title = "Local gene therapy with anti-CD40 siRNA plus rapamycin prolongs survival and decreases post-transplant renal acute rejection",

author = "I. Herrero-Fresneda and O. Gulias and M. Franquesa and R. Pluvinet and A. Vidal and V. Nacher and Cruzado, \{J. M.\} and I. Rama and J. Aran and Grinyo, \{J. M.\} and J. Torras",

year = "2007",

month = sep,

language = "English",

volume = "20",

pages = "68--68",

journal = "Transplant International",

issn = "0934-0874",

publisher = "Frontiers Media S.A.",

}

TY - JOUR

T1 - Local gene therapy with anti-CD40 siRNA plus rapamycin prolongs survival and decreases post-transplant renal acute rejection

AU - Herrero-Fresneda, I.

AU - Gulias, O.

AU - Franquesa, M.

AU - Pluvinet, R.

AU - Vidal, A.

AU - Nacher, V.

AU - Cruzado, J. M.

AU - Rama, I.

AU - Aran, J.

AU - Grinyo, J. M.

AU - Torras, J.

PY - 2007/9

Y1 - 2007/9

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=pure_univeritat_ramon_llull&SrcAuth=WosAPI&KeyUT=WOS:000249954000248&DestLinkType=FullRecord&DestApp=WOS_CPL

M3 - Meeting Abstract

SN - 0934-0874

VL - 20

SP - 68

EP - 68

JO - Transplant International

JF - Transplant International

ER -

Local gene therapy with anti-CD40 siRNA plus rapamycin prolongs survival and decreases post-transplant renal acute rejection

Other files and links

Cite this